Le Lézard
Classified in: Health
Subject: SVY

Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2017



LONDON, Oct. 6, 2017 /PRNewswire/ -- Summary



Download the full report: https://www.reportbuyer.com/product/3984749


GlobalData's Medical Devices sector report, "Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2017" provides an overview of Drug Delivery Infusion Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Drug Delivery Infusion Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
- Extensive coverage of the Drug Delivery Infusion Systems under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Drug Delivery Infusion Systems and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Drug Delivery Infusion Systems under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Download the full report: https://www.reportbuyer.com/product/3984749

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com  

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 01:47
Bayan Grocers Inc. is recalling Polly Ann brand frozen dessert bars from the marketplace because they contain milk which is not declared on the label. People with an allergy to milk should not consume the recalled products described below. The...

15 déc 2017
ESSA Pharma Inc. ("ESSA" or the "Company") announces an update to its previously announced pricing press release. The Company intends to issue up to 75,000,000 units of the Company ("Units") at a price of US$0.20 per Unit (the "Offering Price") for...

15 déc 2017
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Endologix, Inc. .   On August 2, 2016,...

15 déc 2017
The food recall warning issued on December 9, 2017 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation. Imperial Caviar...

15 déc 2017
Valeant Pharmaceuticals International, Inc. ("Valeant") announced today the results to date of the pending cash tender offers (the "Tender Offers") by Valeant and Valeant Pharmaceuticals International ("VPI," and together with Valeant, the...

15 déc 2017
Recognizing that Centene Corporation's Washington subsidiary, Coordinated Care, has been in active discussions with the State of Washington Office of the Commissioner (OIC) for some time, today Coordinated Care finalized the terms of an agreement...




News published on 6 october 2017 at 09:05 and distributed by: